Diabetes Drugs

Diabetes Drugs

Diabetes tablets and drugs from Zenomed Healthcare are manufactured in compliance with eGMP certification. We undertake contract manufacturing orders under the name and brand of our customers.

TENELIGLIPTIN TABLETS 20 mg

Each film-coated tablet contains:

  • Teneligliptin Hydrobromide Hydrate
    Equivalent to Teneligliptin 20 mg

GLIMEPIRIDE TABLETS IP 1 mg

Each uncoated tablet contains:

  • Glimepiride IP 1 mg

 

GLIMEPIRIDE TABLETS IP 2 mg

Each uncoated tablet contains:

  • Glimepiride IP 2 mg

VOGLIBOSE TABLETS IP 0.2 mg

Each uncoated tablet contains:

  • Voglibose IP 0.2 mg

 

VOGLIBOSE TABLETS IP 0.3 mg

Each uncoated tablet contains:

  • Voglibose IP 0.3 mg

METFORMIN HYDROCHLORIDE TABLETS IP

Each uncoated tablet contains:

  • Metformin hydrochloride IP 500 mg

 

METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS IP

Each uncoated tablet contains:

  • Metformin Hydrochloride IP 500 mg

  • Glimepiride IP 1 mg

METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS IP

Each uncoated tablet contains:

  • Metformin Hydrochloride IP 500 mg
    (as prolonged-release)

  • Glimepiride IP 2 mg

 

METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS 1 Mg

Each uncoated tablet contains:

  • Metformin Hydrochloride IP 1000 mg
    (as prolonged-release)

  • Glimepiride IP 1 mg

METFORMIN HYDROCHLORIDE SUSTAINED RELEASE AND GLIMEPIRIDE TABLETS - 2 mg

Each uncoated tablet contains:

  • Metformin Hydrochloride IP 1000 mg
    (as prolonged-release)

  • Glimepiride IP 2 mg

 

METFORMIN HYDROCHLORIDE AND VOGLIBOSE TABLETS

Each uncoated tablet contains:

  • Metformin Hydrochloride IP 500 mg
    (as prolonged- release)

  • Voglibose IP 0.3 mg

GLICLAZIDE MODIFIED RELEASE AND METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS

Each uncoated bi-layered tablet contains:

  • Gliclazide IP 60 mg
    (as modified release)

  • Metformin Hydrochloride IP 500 mg
    (Sustained release)

 

METFORMIN HYDROCHLORIDE AND ALPHA LIPOIC ACID TABLETS

Each film-coated tablet contains:

  • Metformin Hydrochloride IP 500 mg

  • Alpha Lipoic Acid USP 200 mg

METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP 1000 mg

Each uncoated prolonged release tablet contains:

  • Metformin Hydrochloride IP 1000 mg
    (as prolonged-release)

 

OLMESARTAN MEDOXOMIL TABLETS IP 40 mg

Each film-coated tablet contains:

  • Olmesartan Medoxomil IP 40 mg

NITROGLYCERIN CONTROLLED RELEASE TABLETS

Each uncoated controlled release tablet contains:

  • Diluted Nitroglycerin IP 2.6 mg
    Equivalent to Nitroglycerin
    (as controlled release)

 

PROPRANOLOL HYDROCHLORIDE TABLETS IP 10 mg

Each uncoated tablet contains:

  • Propranolol Hydrochloride IP 10 mg

PROPRANOLOL HYDROCHLORIDE TABLETS IP 40 mg

Each uncoated tablet contains:

  • Propranolol Hydrochloride IP 40 mg

 

PROPRANOLOL HYDROCHLORIDE PROLONGED RELEASE TABLETS 80 mg

Each uncoated prolonged-release contains:

  • Propranolol Hydrochloride IP 80 mg
    (as prolonged-release)

CILNIDIPINE TABLETS IP 5 mg

Each uncoated tablet contains:

  • Cilnidipine IP 5 mg

 

CILNIDIPINE TABLETS IP 10 mg

Each uncoated tablet contains:

  • Cilnidipine IP 10 mg

NEBIVOLOL TABLETS IP 5 mg

Each film-coated tablet contains:

  • Nebivolol Hydrochloride IP 5 mg
    Equivalent to Nebivolol

 

BENIDIPINE HYDROCHLORIDE TABLETS

Each film-coated tablet contains:

  • Benidipine Hydrochloride IP 4 mg

BENIDIPINE HYDROCHLORIDE TABLETS    

Each film-coated tablet contains:

  • Benidipine Hydrochloride  IP  8 mg

Request for Information

For more information, please fill the form below and we will be in touch.

 
 

Our Product Range

Product Overview Aminoacids, Multi-Vitamin, Minerals, Iron & Antioxidant Drugs Antiemetic Tablets Antibiotic Drugs Anti-epileptic Drugs Anti-proliferative Drugs Anti-platelet Drugs Antihistamine Drugs Cardiac Drugs Diabetes Drugs Dermatology Drugs FSSAI Drugs General Drugs Gastroenterology Drugs Neurology Drugs Orthopaedics & Painkiller Products Psychiatric Drugs Urology Drugs